期刊文献+

不同激素应用方案下肉芽肿乳腺炎症妇女的疗效与安全性对比

Comparison of the efficacy and safety of granulomatous mastitis in women under different hormonal application regimens
下载PDF
导出
摘要 〔目的〕探究不同激素应用方案下肉芽肿乳腺炎症(GM)妇女的疗效与安全性,为肉芽肿乳腺炎症患者的治疗与预后提供参考。〔方法〕选取2016年6月至2018年6月某医院收治的GM患者246例,根据不同激素应用方案将所有患者分为疼痛用药组(n=109)、冲击用药组(n=46)、持续用药组(n=42)及指标用药组(n=49)。观察并比较各组患者手术中切除腺体量及出血量、手术后引流液变淡时间及引流量、术后1年复发情况及不良反应发生情况。〔结果〕各组患者术中切除腺体量及出血量、术后引流液变淡时间及引流量、术后1年内复发率比较差异均没有统计学意义(P>0.05);与持续用药组指标用药组相比,疼痛用药组及冲击用药组患者不良反应发生率较低,比较差异有统计学意义(P<0.05);疼痛用药组患者不良反应发生率明显高于冲击用药组,差异具有统计学意义(P<0.05)。〔结论〕在GM患者的治疗中增加激素类药物药量不能达到提高治疗效果及预后的目的,大剂量使用激素类药物在短时间内行冲击治疗,有利于降低患者不良反应的发生率。 〔Objective〕To explore the efficacy and safety of granulomatous mastitis in women under different hormonal regimens,to provide reference for clinical treatment and prognosis of patients with granulomatous mastitis.〔Methods〕246 patients with granulomatous breast inflammation admitted to a hospital from June 2016 to June 2018 were selected,according to different hormone application programs,all patients were divided into pain medication group(n=109),impact medication group(n=46),continuous medication group(n=42)and index medication group(n=49).The surgical removal of gland volume and bleeding volume,the time of postoperative drainage fluid dilution and drainage volume,one year postoperative recurrence,and the incidence of adverse reactions in each group of patients were observed and compared.〔Results〕There was no statistically significant difference in the surgical removal of gland volume and blood loss during operation,the time of postoperative drainage fluid dilution and drainage volume,and the recurrence rate within one year after surgery in each group(P>0.05);compared with the continuous medication group and the index medication group,the incidence of adverse reactions was lower in the pain medication group and the impact medication group,the difference was statistically significant(P<0.05);the incidence of adverse reactions in the pain medication group was significantly higher than that in the impact medication group,the difference was statistically significant(P<0.05).〔Conclusion〕Increasing the dosage of hormone drugs in the treatment of GM patients can t achieve the purpose of improving the therapeutic effect and prognosis,but high-dose hormonal drugs are used for pulse therapy in the short time,which is helpful to reduce the incidence of adverse reactions in patients.
作者 龚子永 GONG Ziyong(Department of Breast Surgery,Xinxiang First People s Hospital,Xinxiang 453000,China)
出处 《河南大学学报(医学版)》 CAS 2020年第4期256-259,共4页 Journal of Henan University:Medical Science
基金 河南省科技攻关计划项目(2016013320)。
关键词 肉芽肿乳腺炎症 地塞米松 疗效 安全性 granulomatous mastitis dexamethasone effect safety
  • 相关文献

参考文献12

二级参考文献70

  • 1陈吉兵,闵三旭,李岳林,张思永.肉芽肿性小叶性乳腺炎个体化诊治方案的临床研究[J].中华临床医师杂志(电子版),2012,6(21):6966-6968. 被引量:9
  • 2吴航洲,李峥,金维佳.乳腺癌患者的疾病不确定感及其与社会支持的相关性研究[J].中华护理杂志,2006,41(2):101-104. 被引量:106
  • 3Imoto S,Kitaya T,Kodama T,et al.Idiopathic granulomatous mastitis:case report and review of the literature.Jpn J Clin Oncol,1997,27:274-277.
  • 4De Hertogh DA,Rossof AH,Harris AA,et al.Prednisone management of granulomatous mastitis.N Engl J Med,1980,303:799-800.
  • 5Raj N,Macmillan RD,Ellis IO,et al.Rheumatologists and breasts:immunosuppressive therapy for granulomatous mastitis.Rheumatology,2004,43:1055-1056.
  • 6Kim J,Tymms KE,Buckingham JM.Methotrexate in the treatment of granulomatous mastitis.ANZ J Surg,2003,73:247-249.
  • 7Kessler E,Wolloch Y.Granulomatous mastitis:a lesion clinically simulating carcinoma.Am J Clin Pathol,1972,58:642-646.
  • 8Going JJ,Anderson TJ,Wilkinson S,et al.Granulomatous lobular mastitis.J Clin Pathol,1987,40:535-540.
  • 9Akcan A,Akyildiz H,Deneme MA,et al.Granulomatous lobular mastitis:a complex diagnostic and therapeutic problem.World J Surg,2006,30:1403-1409.
  • 10Fiehn C.Methotrexate in rheumatology.Z Rheumatol,2009,68:747-756.

共引文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部